Bulletin
Investor Alert

New York Markets Open in:

press release

May 25, 2021, 8:00 a.m. EDT

Twist Bioscience to Present at Upcoming Virtual Conferences

Twist Bioscience Corporation /zigman2/quotes/207089457/composite TWST +2.60% , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences:

  • Jefferies Virtual Healthcare Conference on Tuesday, June 1; standard presentation at 11:30 a.m. Eastern Time.

  • Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8; fireside chat at 3:50 p.m. Eastern Time.

The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here . A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005260/en/

SOURCE: Twist Bioscience Corporation

Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com

COMTEX_387241690/2456/2021-05-25T08:00:15

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2021

/zigman2/quotes/207089457/composite
US : U.S.: Nasdaq
$ 119.08
+3.02 +2.60%
Volume: 357,758
July 29, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$5.67 billion
Rev. per Employee
$171,619
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.